Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (Aml) in First Remission Receiving Oral Azacitidine (Oral-Aza) in the Randomized, Placebo-Controlled, Phase 3 Quazar Aml-001 Maintenance Trial
AuthID
P-00W-AGM
P-00W-AGM